Evaluating the Impact of a Supportive Care Program

Morality Clinical Trial

Official title:

Evaluating the Impact of a Supportive Care Program

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04971278
• Other study ID #: QI-High Risk
• Status: Completed
• Start date: November 7, 2019
• Est. completion date: September 22, 2022

Study information

• Verified date: July 2023
• Source: NYU Langone Health
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

NYU's High Risk Program targets patients who may be more likely to have increased hospitalization due to health conditions that may cause death in the near future. Community Health Workers, a home visiting doctor service, a supportive care nurse, and behavioral health specialist engage the population to address a range of biopsychosocial needs with end goal in increasing support in the community and engaging palliative and hospice care when appropriate to prevent hospital readmissions, shorten length of stay, reduce hospital utilization, and decrease overall patient cost with a focus on hospital spend.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 1201
• Est. completion date: September 22, 2022
• Est. primary completion date: February 28, 2022
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• 18 years or older

• at or above the 75th percentile on the Mortality Model

• Attributed to a value based contract

Exclusion Criteria:

• Less than 18 years of age

• Below the 75th percentile on the Mortality Model

• Not attributed to a value based contract

Related Conditions & MeSH terms

• Morality
• Patient Engagement

Intervention

Behavioral:
• Supportive care program
Community Health Workers, a home visiting doctor service, a supportive care nurse, and behavioral health specialist engage the population to address a range of biopsychosocial needs with end goal in increasing support in the community and engaging palliative and hospice care when appropriate to prevent hospital readmissions, shorten length of stay, reduce hospital utilization, and decrease overall patient cost with a focus on hospital spend.

Locations

Country	Name	City	State
United States	NYU Langone Health	New York	New York

Sponsors (1)

Lead Sponsor	Collaborator
NYU Langone Health

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Rate of Advance Care Planning note creation	How many and how often are ACP notes written for patients	2 years